These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 6606652)

  • 1. Immunosuppression by D-penicillamine in vitro. Inhibition of human T lymphocyte proliferation by copper- or ceruloplasmin-dependent generation of hydrogen peroxide and protection by monocytes.
    Lipsky PE
    J Clin Invest; 1984 Jan; 73(1):53-65. PubMed ID: 6606652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suggested mode of action of D-penicillamine as an immunosuppressive agent in rheumatoid arthritis.
    Lipsky PE
    Z Rheumatol; 1988; 47 Suppl 1():6-8. PubMed ID: 2975107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-Penicillamine: analysis of the mechanism of copper-catalyzed hydrogen peroxide generation.
    Starkebaum G; Root RK
    J Immunol; 1985 May; 134(5):3371-8. PubMed ID: 2984288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of D-penicillamine on mitogen-induced human lymphocyte proliferation: synergistic inhibition by D-penicillamine and copper salts.
    Lipsky PE; Ziff M
    J Immunol; 1978 Mar; 120(3):1006-13. PubMed ID: 632576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro production and scavenging of hydrogen peroxide by D-penicillamine. Relationship to copper availability.
    Staite ND; Messner RP; Zoschke DC
    Arthritis Rheum; 1985 Aug; 28(8):914-21. PubMed ID: 4026887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of human fibroblast proliferation by D-penicillamine and copper sulfate in vitro.
    Matsubara T; Hirohata K
    Arthritis Rheum; 1988 Aug; 31(8):964-72. PubMed ID: 3261590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human helper T cell function in vitro by D-penicillamine and CuSO4.
    Lipsky PE; Ziff M
    J Clin Invest; 1980 May; 65(5):1069-76. PubMed ID: 6965944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine.
    Matsubara T; Saura R; Hirohata K; Ziff M
    J Clin Invest; 1989 Jan; 83(1):158-67. PubMed ID: 2463265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppression by the disease modifying antirheumatic drug bucillamine: inhibition of human T lymphocyte function by bucillamine and its metabolites.
    Hashimoto K; Lipsky PE
    J Rheumatol; 1993 Jun; 20(6):953-7. PubMed ID: 8350330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppression by captopril in vitro: inhibition of human natural killer activity by copper-dependent generation of hydrogen peroxide.
    Sugiyama E; Iwata M; Yamashita N; Yoshikawa T; Maruyama M; Yano S
    Jpn J Med; 1986 May; 25(2):149-54. PubMed ID: 3528599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-penicillamine cooperates with copper sulfate to enhance the surface expression of functional Fas antigen in rheumatoid synovial fibroblasts via the generation of hydrogen peroxide.
    Harada S; Sugiyama E; Taki H; Shinoda K; Fujita T; Maruyama M; Kobayashi M
    Clin Exp Rheumatol; 2002; 20(4):469-76. PubMed ID: 12175101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of human antibody production in vitro by D-penicillamine and CuSO4: inhibition of helper T cell function.
    Lipsky PE
    J Rheumatol Suppl; 1981; 7():69-73. PubMed ID: 6971939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of KE-758; an active metabolite of the new anti-rheumatic drug KE-298, D-penicillamine, bucillamine and auranofin on the proliferation of murine lymphocytes, and the production of nitric oxide by murine macrophages.
    Inoue T; Takeshita K; Fukushima K
    Int Immunopharmacol; 2001 May; 1(5):833-42. PubMed ID: 11379039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B lymphocyte function in patients with rheumatoid arthritis: impact of regulatory T lymphocytes and macrophages--modulation by antirheumatic drugs.
    Petersen J
    Dan Med Bull; 1988 Apr; 35(2):140-57. PubMed ID: 3282810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of mitogen-induced response of human peripheral blood mononuclear cells by bucillamine, a new antirheumatic sulfhydryl drug.
    Akamatsu T; Matsubara T; Saegusa Y; Mizuno K
    Rheumatol Int; 1994; 13(5):197-201. PubMed ID: 8202663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [D-penicillamine: mechanism of cellular action and induced autoimmune diseases].
    Meyer O
    Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):15-20. PubMed ID: 2939541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation into copper catalyzed D-penicillamine oxidation and subsequent hydrogen peroxide generation.
    Gupte A; Mumper RJ
    J Inorg Biochem; 2007 Apr; 101(4):594-602. PubMed ID: 17275091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of B cell function by bucillamine, a novel disease-modifying antirheumatic drug.
    Hirohata S; Lipsky PE
    Clin Immunol Immunopathol; 1993 Jan; 66(1):43-51. PubMed ID: 8440072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the iodination reaction in normal human neutrophils and in whole blood by penicillamine, congeners and intracellular enzyme catalase and superoxide dismutase.
    Mahlis E; Christophidis N
    Clin Exp Rheumatol; 1989; 7(4):365-71. PubMed ID: 2556228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitory effect of D-penicillamine on human lymphocyte cultures stimulated by phytohaemagglutinin, the antagonistic action of L-cysteine and synergistic inhibition by copper sulphate.
    Room G; Roffe L; Maini RN
    Scand J Rheumatol Suppl; 1979; (28):47-57. PubMed ID: 287191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.